Dataset Information


EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation.

ABSTRACT: Psoriasis is characterized by keratinocyte hyperproliferation. While significant progress has been made in understanding the molecular mechanism regulating the proliferation of keratinocytes, little is known about the epigenetic factors that control this process. EZH2 and EZH2 mediated trimethylation of histone H3 lysine 27 (H3K27me3) was previously shown ectopically expressed in carcinoma and mediated proliferation, thereby we sought to clarify the role of EZH2-H3K27me3 in the proliferation of psoriatic keratinocyte. Interestingly, we found that EZH2 and H3K27me3 were both overexpressed in the epidermis of psoriatic lesional skin compared to normal skin. In vitro, the expression of EZH2 and H3K27me3 was stimulated in human keratinocytes treated with mixture of psoriasis-related cytokines pool (TNF-?, IFN-?, IL-17A, and IL-22). Knockdown of EZH2 significantly reduced keratinocyte proliferative activity. Results from mRNA microarray analysis suggested that Kallikrein-8 (KLK8) might be the target gene of EZH2 in psoriatic keratinocytes. Overexpression or knockdown KLK8 could partially reverse the abnormal proliferation of keratinocytes caused by knockdown or overexpression of EZH2. In vivo, the inhibitor of EZH2, GSK126 could ameliorate the imiquimod-induced psoriasiform lesion. These results suggest that EZH2 might be a therapeutic target for the treatment of psoriasis.

PROVIDER: S-EPMC7532974 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8558409 | BioStudies
| S-EPMC7598068 | BioStudies
| S-EPMC3828049 | BioStudies
| S-EPMC6095711 | BioStudies
| S-EPMC4941040 | BioStudies
| S-EPMC3043053 | BioStudies
| S-EPMC8250439 | BioStudies
| S-EPMC4506511 | BioStudies
| S-EPMC7202509 | BioStudies
2008-01-01 | S-EPMC2490730 | BioStudies